We are live on ! Find out more
CD

Christopher Davis Davis Selected Advisers

AUM $23.3B
1-Year Est. Return 26.95%
 

Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.95%
3 Year Est. Return
+93.11%
5 Year Est. Return
+96.73%
10 Year Est. Return
+388.76%
AUM
$22.9B
AUM Growth
-$331M
Cap. Flow
-$1.06B
Cap. Flow %
-4.63%
Top 10 Hldgs %
47.88%
Holding
146
New
5
Increased
59
Reduced
74
Closed
4

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$550M
2
AMZN icon
Amazon
AMZN
+$169M
3
JPM icon
JPMorgan Chase
JPM
+$152M
4
V icon
Visa
V
+$95.4M
5
UNH icon
UnitedHealth
UNH
+$66.7M

Sector Composition

Rank Sector Weight
1 Financials 38.79%
2 Consumer Discretionary 13.4%
3 Communication Services 12.27%
4 Energy 10.41%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUZ icon
101
Cousins Properties
CUZ
$4.89B
$11M 0.05%
311,919
-4
-0% -$138
FRT icon
102
Federal Realty Investment Trust
FRT
$10.1B
$10.8M 0.05%
85,356
+342
+0.4% +$44.1K
HST icon
103
Host Hotels & Resorts
HST
$15.9B
$9.84M 0.04%
538,387
+2,452
+0.5% +$45K
EQM
104
DELISTED
EQM Midstream Partners, LP
EQM
$9.76M 0.04%
130,812
-1,540
-1% -$115K
LSI
105
DELISTED
Life Storage, Inc.
LSI
$9.76M 0.04%
197,582
+6
+0% +$312
SLG icon
106
SL Green Realty
SLG
$4.07B
$9.44M 0.04%
92,139
+1
+0% +$102
AIV
107
Aimco
AIV
$381M
$9.4M 0.04%
1,642,504
+6,494
+0.4% +$37.9K
BXP icon
108
Boston Properties
BXP
$10.8B
$9.14M 0.04%
74,334
-13
-0% -$1.64K
INXN
109
DELISTED
Interxion Holding N.V.
INXN
$9.04M 0.04%
197,445
-660
-0.3% -$28.5K
CUBE icon
110
CubeSmart
CUBE
$9.21B
$8.88M 0.04%
369,315
+1,275
+0.3% +$32.3K
EXR icon
111
Extra Space Storage
EXR
$31B
$8.63M 0.04%
110,658
+5
+0% +$383
HPP
112
Hudson Pacific Properties
HPP
$787M
$8.46M 0.04%
35,371
-5
-0% -$1.2K
EGP icon
113
EastGroup Properties
EGP
$10.8B
$8.16M 0.04%
97,416
-2
-0% -$161
FCE.A
114
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$6.9M 0.03%
285,566
+1,213
+0.4% +$28K
CXO
115
DELISTED
CONCHO RESOURCES INC.
CXO
$6.61M 0.03%
+54,398
New +$6.88M
TCOM icon
116
Trip.com Group
TCOM
$29B
$6.44M 0.03%
119,561
+25,270
+27% +$1.34M
VTR icon
117
Ventas
VTR
$47.7B
$6.28M 0.03%
90,422
+7
+0% +$466
IBN icon
118
ICICI Bank
IBN
$107B
$6.19M 0.03%
690,574
-1
-0% -$8
CPT icon
119
Camden Property Trust
CPT
$10.8B
$6.17M 0.03%
72,169
+14
+0% +$1.17K
LTRPA
120
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$6.08M 0.03%
523,824
-58,540
-10% -$762K
REXR icon
121
Rexford Industrial Realty
REXR
$8.3B
$5.75M 0.03%
209,680
+22
+0% +$572
CHUBK
122
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$3.22M 0.01%
184,508
-20,010
-10% -$330K
CDR
123
DELISTED
Cedar Realty Trust, Inc
CDR
$2.7M 0.01%
84,243
-38
-0% -$1.29K
RPT
124
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$2.67M 0.01%
207,051
+31,691
+18% +$421K
KRG icon
125
Kite Realty
KRG
$5.24B
$2.65M 0.01%
140,017
-62
-0% -$1.22K

Similar funds

Christopher Davis's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.

  • Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
  • Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
  • Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
  • Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
  • Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
  • Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
  • Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.

Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.